ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Charles J. DiCorte
James E. Davis
P. Michael McFadden
John L. Ochsner
Clifford H. Van Meter, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toda, K.
Right arrow Articles by Van Meter, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toda, K.
Right arrow Articles by Van Meter, C. H., Jr
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;74:2082-2087
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Revascularization in severe ventricular dysfunction (15% <= LVEF <= 30%): a comparison of bypass grafting and percutaneous intervention

Koichi Toda, MD, PhDa, Karen Mackenzie, MDa, Mandeep R. Mehra, MDa, Charles J. DiCorte, MDa, James E. Davis, MDa, P. Michael McFadden, MDa, John L. Ochsner, MDa, Christopher White, MDa, Clifford H. Van Meter, Jr, MDa*

a Department of Surgery and Cardiology, New Orleans, Louisiana, USA

Accepted for publication July 26, 2002.

* Address reprint requests to Dr Van Meter, Division of Thoracic Cardiovascular Surgery, Department of Surgery, Ochsner Clinic, 1514 Jefferson Highway, New Orleans, LA 07121; USA.
e-mail: cvanmeter{at}ochsner.org

Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2002.

BACKGROUND: We sought to determine the optimal approach to revascularization of patients with severe left ventricular (LV) dysfunction.

METHODS: We conducted a single-center observational study of 117 consecutive patients who had severe LV dysfunction (15% <= LV ejection fraction <= 30%) and underwent either coronary artery bypass grafting (CABG, n = 69) or percutaneous revascularization (n = 48) between 1992 and 1997.

RESULTS: The CABG group was younger (62 versus 67 years, p = 0.026), and fewer previous bypasses (7% versus 40%, p < 0.0001) and fewer prior percutaneous revascularizations (16% versus 42%, p = 0.0019) were noted. More vessels were revascularized (3 ± 0.8 versus 1.5 ± 0.7, p < 0.0001), and revascularization was more complete by CABG (84% versus 48%, p < 0.0001). Morbidity and mortality at 30 days were similar, and there was no significant difference in 3-year survival (73% versus 67%), although 3-year cardiac event-free survival (52% versus 25%, p = 0.0011) and 3-year target vessel revascularization–free survival (71% versus 41%, p < 0.0001) were significantly better in the CABG group, and LV ejection fraction was significantly improved after CABG. In the subgroup of patients 65 years of age or older and those without proximal left anterior descending coronary artery lesions, significant benefit of CABG in cardiac event-free and target vessel revascularization–free survival disappeared.

CONCLUSIONS: We found that in clinically selected patients with severe ventricular dysfunction, CABG compared with percutaneous revascularization achieves more complete revascularization, improved LV function, fewer cardiac events, and fewer target vessel revascularizations, but does not affect mid-term survival. A prospective controlled trial with defined criteria for treatment assignment is warranted to confirm our results regarding the two revascularization strategies in patients with severe LV dysfunction.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
P. Chareonthaitawee, B. J. Gersh, P. A. Araoz, and R. J. Gibbons
Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing
J. Am. Coll. Cardiol., August 16, 2005; 46(4): 567 - 574.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
E. E. McCarron, M. J. Shackcloth, A. D. Grayson, and W. C. Dihmis
Left internal mammary artery use in patients with poor left ventricular ejection fraction: a propensity-matched analysis of mid-term survival
Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 184 - 188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.